Trial Profile
Study Evaluating EKB-569 in Advanced Colorectal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Pelitinib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 25 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Sep 2005 New trial record.